It results from the peptides positive charge creating a temporary pH disturbance in the surrounding tissue and is not a sign of contamination, degradation, or an allergic response
So the future for me is how do we make it affordable and how do we make this where everyone can afford it
The Category 2 Ban and the 2026 Reclassification In 2023, the FDA pulled 19 of the most popular peptides BPC-157, TB-500, CJC-1295, among others off the compounding-permitted list and placed them on the restricted Category 2 list, citing safety concerns, impurity issues, and a lack of clinical data
Sources: Kraus D, et al
Realistic Expectations and Long-Term Success B12 injections support your journeythey dont replace healthy habits
I'm really excited to chat with you